The rating action affects $13.5 million of series 2010 bonds, $4.5 million of series 2006A bonds and $18.9 million of series 2006B bonds.
The rating upgrade was supported by a number of factors, including JCSMH’s strong financial profile. In May 2013, the 166-bed hospital defeased $10.5 million of outstanding debt, which reduced JCSMH’s debt burden and enhanced its debt service coverage levels.
The rating upgrade was also supported by the hospital’s dominant market position. JCSMH has a 67 percent market share in its primary service area.
More articles on hospital credit ratings:
Fitch affirms Allina Health’s ‘AA-‘ rating
Moody’s assigns ‘Baa2’ rating on Erlanger Health System bonds, revises outlook
Moody’s affirms ‘Aa3’ rating on Sisters of Charity of Leavenworth Health System’s revenue bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
